Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:13 PM
Ignite Modification Date:
2025-12-24 @ 9:13 PM
NCT ID:
NCT07074704
Eligibility Criteria:
Inclusion Criteria:
* Inclusion criteria for long-term hospitalized schizophrenia patients:
1. Diagnosed with DSM-5 schizophrenia and hospitalized for more than half a year
2. Aged between 18 and 65 years old
3. Willing to participate in the study and sign the informed consent
4. Stable condition, PANSS total score changed less than 15% at least 2 months before the study.
5. Education level above primary school
6. Normal vision or normal after correction
Inclusion criteria for normal control group:
1. No diagnosed mental illness
2. Aged between 18 and 65 years old
3. Willing to participate in the study and sign the informed consent
4. Education level above primary school
5. Normal vision or normal after correction
6. Residents living in Pudong community
Exclusion Criteria:
Exclusion criteria for long-term hospitalization of schizophrenia patients:
1. Combined diagnosis of other mental illnesses in DSM-5
2. History of severe neurological diseases, epilepsy, craniocerebral trauma, etc.
3. Severe organic diseases of the heart, liver, kidney and other organs that are unstable
4. Infectious skin diseases
5. Use of other drugs that affect the results during the study, such as benzodiazepines, non-benzodiazepine sedatives, and psychostimulants
6. Pregnant or lactating women
7. Patients with claustrophobia
8. Patients with alcohol, drugs Abuse history
9. Patients who have received TACS treatment in the past and have no effect or intolerance
Exclusion criteria for normal control group:
1. Patients with a history of severe neurological diseases, epilepsy, craniocerebral trauma, etc.
2. Patients with severe organic diseases that cause instability of organs such as heart, liver, and kidney
3. Patients with infectious skin diseases
4. During the study, drugs that affect the results were used in combination, such as benzodiazepines, non-benzodiazepine sedatives, and psychostimulants
5. Pregnant or lactating women
6. Patients with claustrophobia
7. Patients with a history of alcohol and drug abuse -
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07074704
Study Brief:
Protocol Section:
NCT07074704